For Pharmaceutical Manufacturers
VA Labeler Code Enforcement
VA Labeler Code Enforcement: Why Pharmaceutical Manufacturers Should Prepare Now If your pharmaceutical company relies on a third-party dealer to access the U.S. Department of Veterans Affairs (VA) market, recent activity from the VA Federal Supply Schedule (FSS)...
U.S. Pharmaceutical Tariffs Expand to Generic Drugs
U.S. Pharmaceutical Tariffs Expand to Generic Drugs: What Manufacturers Need to Know When Prescription Analytics first examined pharmaceutical tariff policy in 2025, no pharma-specific framework had been finalized. Since then, the policy has advanced, with a branded...
CMS Confirms Q2 2026 ASP Reporting Requirements for Reasonable Assumptions and BFSF Documentation
CMS Confirms Q2 2026 ASP Reporting Requirements for Reasonable Assumptions and BFSF Documentation CMS has provided updated guidance on the new Average Sales Price (ASP) reporting requirements related to reasonable assumptions and, where applicable, bona fide service...
VA Labeler Code Enforcement
VA Labeler Code Enforcement: Why Pharmaceutical Manufacturers Should Prepare Now If your pharmaceutical company relies on a third-party dealer to access the U.S. Department of Veterans Affairs (VA) market, recent activity from the VA Federal Supply Schedule (FSS)...
U.S. Pharmaceutical Tariffs Expand to Generic Drugs
U.S. Pharmaceutical Tariffs Expand to Generic Drugs: What Manufacturers Need to Know When Prescription Analytics first examined pharmaceutical tariff policy in 2025, no pharma-specific framework had been finalized. Since then, the policy has advanced, with a branded...
CMS Confirms Q2 2026 ASP Reporting Requirements for Reasonable Assumptions and BFSF Documentation
CMS Confirms Q2 2026 ASP Reporting Requirements for Reasonable Assumptions and BFSF Documentation CMS has provided updated guidance on the new Average Sales Price (ASP) reporting requirements related to reasonable assumptions and, where applicable, bona fide service...
Baseline AMP: Guide to Compliance & Profitability
For pharmaceutical manufacturers, a comprehensive understanding of the Baseline Average Manufacturer Price (AMP) is crucial. Its establishment and calculation significantly impact profitability, compliance and long-term value of your product. In this white paper,...
Navigating Texas Medicaid Formulary: Guide for Pharma Mfrs
NAVIGATING THE TEXAS MEDICAID FORMULARY: A Comprehensive Guide for Pharmaceutical ManufacturersThe landscape of pharmaceutical product listing in Texas presents unique challenges for manufacturers seeking Medicaid coverage. Unlike other states, Texas operates its own...
Chargeback Processing: Best Practices to Avoid Revenue Loss
Chargeback Processing — Best Practices to Avoid Revenue Leakage & RiskChargeback processing, validation, and reconciliation are integral in maintaining a profitable business in the highly competitive U.S. pharmaceutical market. Profit margins are tight, especially...
Professor Jeremy’s
KEY TERMS
FOR PHARMA EXECUTIVES
Pharmaceutical professionals often face challenges with the industry’s language, acronyms, and key players. This glossary offers an overview of essential terms every executive should know.